文献速递眼底病与葡萄膜炎

网状假性玻璃膜疣状态、ARMS2/HTRA1基因型与地图样萎缩扩大:年龄相关性眼病研究2报告32

Reticular Pseudodrusen Status, ARMS2/HTRA1 Genotype, and Geographic Atrophy Enlargement: Age-Related Eye Disease Study 2 Report 32.
PubMed 文献 · Ophthalmology · 2022-12-06

该研究为年龄相关性眼病研究2的事后分析,纳入771只地图样萎缩眼,发现网状假性玻璃膜疣(RPD)阳性眼和携带ARMS2/HTRA1风险等位基因者的地图样萎缩扩大速度更快;但RPD状态并未介导ARMS2/HTRA1基因型与扩大速度的关联,两者为相对独立的风险因素;RPD存在不预测地图样萎缩发生时的中央受累或多灶性,但与向中央黄斑进展更快相关。

要点

  • RPD阳性眼地图样萎缩扩大速度显著快于RPD阴性眼(P<0.0001)。
  • 携带ARMS2风险等位基因0、1、2个者扩大速度依次增加(P<0.0001)。
  • RPD状态未介导ARMS2基因型与地图样萎缩扩大速度的关联。

核心结论

  • 地图样萎缩在RPD阳性眼和携带ARMS2/HTRA1风险等位基因者中扩大更快,但RPD状态并不介导该基因型与扩大速度的关联。
  • RPD存在与ARMS2/HTRA1基因型是相对独立的风险因素,通过不同机制发挥作用。
  • RPD存在不预测地图样萎缩发生时的中央受累或多灶性,但与向中央黄斑进展更快相关。

研究设计与样本

  • 年龄相关性眼病研究2队列的事后分析,纳入来自563名参与者的771只地图样萎缩眼。
  • 地图样萎缩面积通过每年访视的眼底照片测量,RPD存在通过眼底自发荧光图像分级。
  • 采用混合模型回归分析地图样萎缩面积平方根,按RPD状态、ARMS2基因型或两者分层。
  • 主要结局指标为地图样萎缩面积平方根的变化。

主要发现

  • RPD阳性眼地图样萎缩扩大速度为0.379 mm/年(95%CI 0.329-0.430),RPD阴性眼为0.273 mm/年(95%CI 0.256-0.289),RPD阳性眼更快(P<0.0001)。
  • 携带0、1、2个ARMS2风险等位基因者扩大速度分别为0.224 mm/年(95%CI 0.198-0.250)、0.287 mm/年(95%CI 0.263-0.310)、0.307 mm/年(95%CI 0.273-0.341),随风险等位基因数增加而加快(P<0.0001)。
  • 中介分析中,ARMS2基因型的直接效应为0.074 mm/年(95%CI 0.009-0.139),经RPD状态的间接效应为0.002 mm/年(95%CI -0.006至0.009)。
  • 在发生地图样萎缩的眼中,RPD存在与发生时的中央受累可能性无关(P=0.29),与多灶性也无关(P=0.16)。
  • 在发生非中央地图样萎缩的眼中,RPD存在与向中央黄斑进展更快相关(P=0.009):157 μm/年(95%CI 126-188) vs 111 μm/年(95%CI 97-125)。

临床怎么用

  • 作者认为,应考虑将RPD状态用于改进地图样萎缩扩大速度的预测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine whether reticular pseudodrusen (RPD) status, ARMS2/HTRA1 genotype, or both are associated with altered geographic atrophy (GA) enlargement rate and to analyze potential mediation of genetic effects by RPD status. DESIGN: Post hoc analysis of an Age-Related Eye Disease Study 2 cohort. PARTICIPANTS: Eyes with GA: n = 771 from 563 participants. METHODS: Geographic atrophy area was measured from fundus photographs at annual visits. Reticular pseudodrusen presence was graded from fundus autofluorescence images. Mixed-model regression of square root of GA area was performed by RPD status, ARMS2 genotype, or both. MAIN OUTCOME MEASURES: Change in square root of GA area. RESULTS: Geographic atrophy enlargement was significantly faster in eyes with RPD (P < 0.0001): 0.379 mm/year (95% confidence interval [CI], 0.329-0.430 mm/year) versus 0.273 mm/year (95% CI, 0.256-0.289 mm/year). Enlargement was also significantly faster in individuals carrying ARMS2 risk alleles (P < 0.0001): 0.224 mm/year (95% CI, 0.198-0.250 mm/year), 0.287 mm/year (95% CI, 0.263-0.310 mm/year), and 0.307 mm/year (95% CI, 0.273-0.341 mm/year) for 0, 1, and 2, respectively. In mediation analysis, the direct effect of ARMS2 genotype was 0.074 mm/year (95% CI, 0.009-0.139 mm/year), whereas the indirect effect of ARMS2 genotype via RPD status was 0.002 mm/year (95% CI, -0.006 to 0.009 mm/year). In eyes with incident GA, RPD presence was not associated with an altered likelihood of central involvement (P = 0.29) or multifocality (P = 0.16) at incidence. In eyes with incident noncentral GA, RPD presence was associated with faster GA progression to the central macula (P = 0.009): 157 μm/year (95% CI, 126-188 μm/year) versus 111 μm/year (95% CI, 97-125 μm/year). Similar findings were observed in the Age-Related Eye Disease Study. CONCLUSIONS: Geographic atrophy enlargement is faster in eyes with RPD and in individuals carrying ARMS2/HTRA1 risk alleles. However, RPD status does not mediate the association between ARMS2/HTRA1 genotype and faster enlargement. Reticular pseudodrusen presence and ARMS2/HTRA1 genotype are relatively independent risk factors, operating by distinct mechanisms. Reticular pseudodrusen presence does not predict central involvement or multifocality at GA incidence but is associated with faster progression toward the central macula. Reticular pseudodrusen status should be considered for improved predictions of enlargement rate. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Agrón E, Domalpally A, Cukras CA, et al. Reticular Pseudodrusen Status, ARMS2/HTRA1 Genotype, and Geographic Atrophy Enlargement: Age-Related Eye Disease Study 2 Report 32. Ophthalmology. 2022. PMID: 36481221. doi:10.1016/j.ophtha.2022.11.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。